Biotech · Private company
NanoCarrier Co., Ltd.
Track this companyFree. Adds NanoCarrier Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- 5-FUPhase 2 · Carcinoma, Squamous Cell of Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 2 · Carcinoma, Squamous Cell of Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- NC 6300Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- NC-6004Phase 2 · Carcinoma, Squamous Cell of Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
- NC-6004Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue SarcomaPHASE1_PHASE2 · UNKNOWN · started Jun 30, 2017ClinicalTrials.gov NCT03168061 · fetched Nov 12, 2026
- NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckPHASE1_PHASE2 · COMPLETED · started Mar 1, 2017ClinicalTrials.gov NCT03109158 · fetched Nov 12, 2026
- Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder CancerPHASE1_PHASE2 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02240238 · fetched Nov 12, 2026